Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Citrulline and Metformin in Becker's Muscular Dystrophy
NCT02018731Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Jun 2013
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin and citrulline in Becker muscular dystrophy (BMD), sponsored by University Hospital Basel. Primary endpoint: Motor Function Measure D1 subscore at 12 weeks. Started Jun 2013; status: completed.
02
Drugs
metformincitrulline
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT02018731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018731.